Cardiometabolic diseases increase COVID-19 risk

Nov 13, 2020 | Jennifer O'Hara | @jenohara

blood-drop-examination-tool-kit-blood-sugar-tracker-record-and-heart-with-doctors-stethoscope-_shutterstock_717358591_16x9-1536x864

An estimated 47 million Americans are living with cardiometabolic diseases, according to the American College of Cardiology. Cardiometabolic diseases are interrelated conditions that include cardiovascular diseases, such as heart disease, stroke, and hypertension, as well as metabolic diseases, such as Type 2 diabetes, obesity and nonalcoholic fatty liver disease. Patients with cardiometabolic diseases have a higher risk of not only developing COVID-19, but also developing complications related to COVID-19.

On the Mayo Clinic Q&A podcast, Dr. Stephen Kopecky, a Mayo Clinic cardiologist, discusses lifestyle factors that affect cardiometabolic diseases and how COVID-19 can damage the heart

To practice safe social distancing during the COVID-19 pandemic, this interview was conducted using video conferencing.

The sound and video quality are representative of the technology used.

Connect with others talking about the pandemic and supporting one another in the COVID-19 support group and the Heart & Blood Health support group.

 

Please sign in or register to post a reply.